EGFR and non-small cell lung carcinoma: However, the level of PD-L1 expression was not associated with OS (HR = 1.19; 95% CI = 0.99–1.43; P = 0.070) (Fig. 2b) in NSCLC patients treated with EGFR-TKIs.